Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
April 25, 2022
SCOPE 2 - Still Answering the Unanswered Questions in Oesophageal Radiotherapy? SCOPE 2: a Randomised Phase II/III Trial to Study Radiotherapy Dose Escalation in Patients with Oesophageal Cancer Treated with Definitive Chemoradiation with an Embedded Phase II Trial for Patients with a Poor Early Response using Positron Emission Tomography/Computed Tomography
S Bridges, B Thomas, G Radhakrishna, et al.
Radiation Oncology (London, England)
|
February 6, 2019
Driving developments in UK oesophageal radiotherapy through the SCOPE trials
S Gwynne, E Higgins, A Poon King, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
January 9, 2026
Radiotherapy Plan Quality Assurance in the ABC-07 Trial of Stereotactic Body Radiotherapy for Locally Advanced Biliary Tract Cancer
D J Eaton, D H Brand, N Hava, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
January 12, 2025
Radiotherapy Quality Assurance in the SCOPE2 Trial: What Lessons can be Learned for the Next UK Trial in Oesophageal Cancer?
J Helbrow, G Lewis, C Hurt, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
October 20, 2019
An Evaluation Report on Radiotherapy Contouring Workshops During the Royal College of Radiologists' Annual Meeting 2018
M S Iqbal, A Hothi, E S Evans, et al.
Physics and Imaging in Radiation Oncology
|
March 4, 2022
A treatment planning comparison of photon stereotactic ablative radiotherapy and proton beam therapy for the re-irradiation of pelvic cancer recurrence
R Chuter, E Glassborow, R Speight, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
July 24, 2020
Comparative Dosimetric Analysis and Normal Tissue Complication Probability Modelling of Four-Dimensional Computed Tomography Planning Scans Within the UK NeoSCOPE Trial
O Nicholas, C Bowden, A Selby, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
February 10, 2019
Hypofractionated Radiotherapy in Oesophageal Cancer for Patients Unfit for Systemic Therapy: A Retrospective Single-Centre Analysis
C M Jones, K Spencer, C Hitchen, et al.
British Journal of Cancer
|
December 21, 2023
CHARIOT: a phase I study of berzosertib with chemoradiotherapy in oesophageal and other solid cancers using time to event continual reassessment method
S R Javed, S Lord, S El Badri, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
June 9, 2016
Superiority of Deformable Image Co-registration in the Integration of Diagnostic Positron Emission Tomography-Computed Tomography to the Radiotherapy Treatment Planning Pathway for Oesophageal Carcinoma
G Ward, S Ramasamy, J R Sykes, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
April 25, 2022
SCOPE 2 - Still Answering the Unanswered Questions in Oesophageal Radiotherapy? SCOPE 2: a Randomised Phase II/III Trial to Study Radiotherapy Dose Escalation in Patients with Oesophageal Cancer Treated with Definitive Chemoradiation with an Embedded Phase II Trial for Patients with a Poor Early Response using Positron Emission Tomography/Computed Tomography
S Bridges, B Thomas, G Radhakrishna, et al.
Radiation Oncology (London, England)
|
February 6, 2019
Driving developments in UK oesophageal radiotherapy through the SCOPE trials
S Gwynne, E Higgins, A Poon King, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
January 9, 2026
Radiotherapy Plan Quality Assurance in the ABC-07 Trial of Stereotactic Body Radiotherapy for Locally Advanced Biliary Tract Cancer
D J Eaton, D H Brand, N Hava, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
January 12, 2025
Radiotherapy Quality Assurance in the SCOPE2 Trial: What Lessons can be Learned for the Next UK Trial in Oesophageal Cancer?
J Helbrow, G Lewis, C Hurt, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
October 20, 2019
An Evaluation Report on Radiotherapy Contouring Workshops During the Royal College of Radiologists' Annual Meeting 2018
M S Iqbal, A Hothi, E S Evans, et al.
Physics and Imaging in Radiation Oncology
|
March 4, 2022
A treatment planning comparison of photon stereotactic ablative radiotherapy and proton beam therapy for the re-irradiation of pelvic cancer recurrence
R Chuter, E Glassborow, R Speight, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
July 24, 2020
Comparative Dosimetric Analysis and Normal Tissue Complication Probability Modelling of Four-Dimensional Computed Tomography Planning Scans Within the UK NeoSCOPE Trial
O Nicholas, C Bowden, A Selby, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
February 10, 2019
Hypofractionated Radiotherapy in Oesophageal Cancer for Patients Unfit for Systemic Therapy: A Retrospective Single-Centre Analysis
C M Jones, K Spencer, C Hitchen, et al.
British Journal of Cancer
|
December 21, 2023
CHARIOT: a phase I study of berzosertib with chemoradiotherapy in oesophageal and other solid cancers using time to event continual reassessment method
S R Javed, S Lord, S El Badri, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
June 9, 2016
Superiority of Deformable Image Co-registration in the Integration of Diagnostic Positron Emission Tomography-Computed Tomography to the Radiotherapy Treatment Planning Pathway for Oesophageal Carcinoma
G Ward, S Ramasamy, J R Sykes, et al.
Page
of 5